These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 19439166)
1. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Küchler S; Radowski MR; Blaschke T; Dathe M; Plendl J; Haag R; Schäfer-Korting M; Kramer KD Eur J Pharm Biopharm; 2009 Feb; 71(2):243-50. PubMed ID: 18796329 [TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487 [TBL] [Abstract][Full Text] [Related]
4. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions. Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Lv Q; Yu A; Xi Y; Li H; Song Z; Cui J; Cao F; Zhai G Int J Pharm; 2009 May; 372(1-2):191-8. PubMed ID: 19429280 [TBL] [Abstract][Full Text] [Related]
6. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810 [TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
8. Penetration of normal, damaged and diseased skin--an in vitro study on dendritic core-multishell nanotransporters. Alnasif N; Zoschke C; Fleige E; Brodwolf R; Boreham A; Rühl E; Eckl KM; Merk HF; Hennies HC; Alexiev U; Haag R; Küchler S; Schäfer-Korting M J Control Release; 2014 Jul; 185():45-50. PubMed ID: 24727058 [TBL] [Abstract][Full Text] [Related]
9. Influences of opioids and nanoparticles on in vitro wound healing models. Wolf NB; Küchler S; Radowski MR; Blaschke T; Kramer KD; Weindl G; Kleuser B; Haag R; Schäfer-Korting M Eur J Pharm Biopharm; 2009 Sep; 73(1):34-42. PubMed ID: 19344759 [TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related]
11. Skin penetration and distribution of polymeric nanoparticles. Alvarez-Román R; Naik A; Kalia YN; Guy RH; Fessi H J Control Release; 2004 Sep; 99(1):53-62. PubMed ID: 15342180 [TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles for improved topical application of drugs for skin diseases. Schäfer-Korting M; Mehnert W; Korting HC Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165 [TBL] [Abstract][Full Text] [Related]
13. Poly[acrylonitrile-co-(N-vinyl pyrrolidone)] nanoparticles - Composition-dependent skin penetration enhancement of a dye probe and biocompatibility. Zhang N; Said A; Wischke C; Kral V; Brodwolf R; Volz P; Boreham A; Gerecke C; Li W; Neffe AT; Kleuser B; Alexiev U; Lendlein A; Schäfer-Korting M Eur J Pharm Biopharm; 2017 Jul; 116():66-75. PubMed ID: 27989766 [TBL] [Abstract][Full Text] [Related]
14. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Kohli AK; Alpar HO Int J Pharm; 2004 May; 275(1-2):13-7. PubMed ID: 15081134 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Lademann J; Richter H; Teichmann A; Otberg N; Blume-Peytavi U; Luengo J; Weiss B; Schaefer UF; Lehr CM; Wepf R; Sterry W Eur J Pharm Biopharm; 2007 May; 66(2):159-64. PubMed ID: 17169540 [TBL] [Abstract][Full Text] [Related]
16. Skin penetration enhancement of core-multishell nanotransporters and invasomes measured by electron paramagnetic resonance spectroscopy. Haag SF; Fleige E; Chen M; Fahr A; Teutloff C; Bittl R; Lademann J; Schäfer-Korting M; Haag R; Meinke MC Int J Pharm; 2011 Sep; 416(1):223-8. PubMed ID: 21745556 [TBL] [Abstract][Full Text] [Related]
17. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Castro GA; Coelho AL; Oliveira CA; Mahecha GA; Oréfice RL; Ferreira LA Int J Pharm; 2009 Oct; 381(1):77-83. PubMed ID: 19647057 [TBL] [Abstract][Full Text] [Related]
18. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Jensen LB; Petersson K; Nielsen HM Eur J Pharm Biopharm; 2011 Sep; 79(1):68-75. PubMed ID: 21664463 [TBL] [Abstract][Full Text] [Related]
19. Carriers in the topical treatment of skin disease. Korting HC; Schäfer-Korting M Handb Exp Pharmacol; 2010; (197):435-68. PubMed ID: 20217539 [TBL] [Abstract][Full Text] [Related]
20. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]